Speakers

Dr. Michelle Tarver is a visionary public health executive, board-certified in ophthalmology with a doctorate in epidemiology, who serves as the Director of the Center for Devices and Radiological Health.  She has spent more than 15 years as a medical device regulator, driving strategic initiatives, conducting clinical research, and changing organizational culture.  Dr. Tarver has held various leadership positions while at FDA, including the Deputy Director of the Office of Strategic Partnerships and Technology Innovation and the Program Director of Patient Science and Engagement.  Over the course of her career, she has conducted laboratory-based and epidemiological studies, clinical trials, and surveys to capture patient preferences, as well as developed registries and patient-reported outcome measures. Dr. Tarver has extensive policy experience in crafting regulations, guidances, and conducting premarket and postmarket reviews. She most recently served as the Deputy Center Director for Transformation, steering the development, implementation, and direction of CDRH’s transformative projects and strategic initiatives. Under her leadership, CDRH has launched efforts to amplify the perspectives of people living with medical conditions, foster collaboration across the healthcare ecosystem, and stimulate creative evidence generation pathways.  Dr. Tarver received a B.S. in Biochemistry from Spelman College in Atlanta, GA and completed the M.D./Ph.D. program at The Johns Hopkins University School of Medicine and Bloomberg School of Public Health.  As a dedicated clinician, she continues to care for people living with inflammatory eye conditions.

Matt serves as Group Vice President, Supply Chain Operations for MedSurg and Neurotechnology (MSNT) for Stryker. He joined Stryker in 2023 to lead the Global Manufacturing team, where he partnered with commercial and functional leaders to meet customer needs and drove a Lean manufacturing mindset and manufacturing excellence through flexible, scalable and standardized platforms.

With over 25 previous years of extensive manufacturing experience, Matt has a successful track record in the medical device, pharmaceutical and industrial goods industries where he increased efficiency, improved supply chain resilience and enhanced collaboration.

Matt earned his MBA from Harvard Business School and his bachelor’s degree in Manufacturing Engineering from BYU.

Mark P. Brosius is senior vice president and chief manufacturing and supply chain officer at Intuitive, with responsibility for SIOP, supply chain, new product introduction, manufacturing, and logistics operations. Brosius is a leading expert in enterprise scale manufacturing and business process automation, as well as the application of big data and analytics to planning, supply chain, and manufacturing. He brings more than 30 years of experience in multinational manufacturing operations and product development.

Brosius joined Intuitive in 2012 as the founding leader of the manufacturing automation function, before leading new product introduction (NPI) engineering and ultimately all of operations. He was promoted to his current role in 2023.

Prior to joining Intuitive, he served as president and chief technology officer for Harbor Fluid Products, from 2002 to 2011.

Brosius earned a BS in mechanical engineering from Stanford University and completed graduate studies in finance at the University of California, Berkeley. He also holds an honorary degree in engineering management from California Polytechnic University at San Luis Obispo.

Peter Bennett is the Senior Vice President of Global Supply Chain for Cardinal Health. In this role, he is accountable for International Logistics, Global Trade, Global Distribution Operations, Global planning, and key customer collaborative planning, forecasting and replenishment (CPFR) teams. He supports Cardinal Health’s Global medical product brands, national brands, Presource, and AeroMed. Bennett earned a bachelor’s degree from the United States Military Academy at West Point, and a master of science from Central Michigan University. He is a member of the Association of Supply Chain Management (ASCM) and currently services as a Co-Chair of Healthcare Industry Distributor Association (HIDA) supply chain visibility council and is on the supplier advisory council of the Healthcare Industry Resilience Collaborative (HIRC).

Terry Walsh serves as the Global Vice President of Operations at Beckman Coulter, a Danaher Company, where he is responsible for the comprehensive oversight of Manufacturing, Supply Chain Planning, Strategic Sourcing, Distribution & Logistics, Transformation/PMO, Enterprise Operational Risk, EHS, Operations Engineering, and the effective implementation of the Danaher Business System (DBS). His leadership directly impacts all businesses and channels across the extensive global network.

A staunch advocate for Danaher’s core value, “The Best Team Wins,” Terry believes in the power of diverse, inclusive, and collaborative teams to drive innovation, solve complex challenges, and ensure business success. He is deeply committed to fostering a culture of belonging, empowering associates, and achieving superior results through collective effort and data-driven decisions. This commitment extends to his sponsorship of the Operations Talent program across Danaher’s Diagnostics platform, championing continuous learning and development.

With over 30 years of distinguished experience, Terry has a proven track record in Supply Chain, Manufacturing, Organizational Development, and Global Operations leadership. Before joining Beckman Coulter in 2024, he successfully led global operations at SI Group and held significant leadership positions at Wilsonart, Henkel, Novartis, Merck, and Johnson & Johnson. His career spans both public and private equity environments, providing a broad strategic perspective. Terry holds a Bachelor of Science in Mechanical Engineering from Rutgers University and a Master of Business Administration in International Finance from Rider University.

Rosaleen Burke, Global Quality and Regulatory, Boston Scientific, is responsible for leading all aspects of the quality and regulatory strategy for the Boston Scientific business and broad portfolio. Roz joined Boston Scientific in 1997 and has led Quality and Regulatory teams across several regions, business units, sites and quality functions in roles of increasing responsibility and scope. Roz began her current position in 2017.

She holds a B.Sc. in Microbiology and Biochemistry and a Master’s degree in Biotechnology from the University of Galway, as well as an MBA from Oxford Brookes University. Outside of her professional pursuits, she enjoys horse riding, golf, reading, and playing Scrabble.

Dina is currently the Vice President of Regulatory Affairs for Terumo Medical Corporation where she oversees both US and global Regulatory Affairs. Prior to joining Terumo in 2008, Dina spent 17 years at the FDA as a reviewer and later a branch chief in the Division of Cardiovascular Devices. She also spent some time as a Sr. RA consultant prior to joining Terumo.

Dina holds a BS in Biomedical Engineering from The Catholic University of America and a Master of Business Administration from the University of Maryland.

Mizanu Kebede is the Chief Quality & Regulatory Officer at Smith & Nephew and serves on the company’s Executive Leadership Team. In this role, he is responsible for leading all aspects of quality and regulatory strategy development and implementation. He is also responsible for engaging directly with global regulatory agencies on all regulatory matters impacting the company’s diverse portfolio.

With over 25 years of leadership experience across the Medical Device, Pharmaceutical, and Healthcare industries, Mizanu has held senior roles spanning R&D, Operations, Commercial, and Quality & Regulatory Affairs. Prior to joining Smith & Nephew, he held executive positions at several leading healthcare companies, including Avanos Medical, Thermo Fisher Life Technologies, STERIS Corporation, and Johnson & Johnson.

Mizanu holds a Bachelor of Science in Medical Technology and a Master of Science in Microbiology and Immunology. He is a certified Six Sigma Black Belt in Process Excellence and has authored numerous publications in scientific journals. He also holds multiple patents in the medical device space.

In addition to his professional accomplishments, Mizanu is committed to community service. He serves as an Advisory Board Member for United Way of North Fulton and is actively involved with the United Way of Greater Atlanta.

Steve C de Baca is Executive Vice President and Chief Patient Safety & Quality Officer of Royal Philips. He brings more than 35 years of quality and regulatory affairs (QRA) experience in the medical technology industry.

Prior to joining Philips in February 2023, Steve served as the EVP of QRA for Cardinal Health, supporting the $185B enterprise and was a member of the Operating Committee.

Prior to this, Steve served as VP of QRA for Orthopedics and Americas for Zimmer Biomet, where he was responsible for supporting multiple business segments as well as the Americas region for international regulatory and compliance. Earlier in his career, he served as the SVP of Quality, Regulatory & Clinical Affairs for the Danaher Diagnostic platform, which includes the four separate operating companies of Beckman Coulter Diagnostics, Leica Biosystems, Radiometer & Cepheid. Prior to that, Steve was with Boston Scientific for nearly nine years in progressively senior strategic roles, the last of which was VP of Quality, for the Cardio, Rhythm, and Vascular (CRV) and the Neuromodulation businesses.

Additionally, Steve served as an industry board member and instructor for six years for the Regulatory Affairs master’s degree program at St. Cloud State University. He earned a bachelor’s degree in engineering and industrial technology and an MBA, both at California State University Long Beach.

He lives in Minnesota and has been married to his wife Katherine for over 26 years. They are proud of their son Carson who is a graduate from Northeastern University in Boston and currently living in Chicago. Steve is an avid runner and sports enthusiast.

David Kunz was appointed Senior Vice President, Global Quality and Regulatory Affairs in May 2017. He is responsible for providing strategic and operational direction to achieve Quality and Regulatory Excellence across the Zimmer Biomet organization. Mr. Kunz joined the Company (then Zimmer) in 2011 as Vice President, Regulatory Affairs and Quality Assurance for the Spine division. He was appointed Senior Vice President, Global Quality, Clinical and Regulatory Affairs in April 2016.  Prior to joining Zimmer, he served as Vice President, Quality Assurance of Ecolab, where he led a supply chain network including nine chemical plants and two equipment plants. Previously, he spent 13 years at Guidant/Boston Scientific Corporation in a variety of leadership positions, most recently as the Director of Supplier Quality Assurance for the CRV Division. He began his career at the Naval Nuclear Propulsion Program Headquarters as a mechanical engineer. Mr. Kunz holds a Bachelor of Science and an MBA from the University of Minnesota. He is a certified Nuclear Engineer and previously was a certified Licensed Professional Mechanical Engineer.

Jamie Kinzer is a global end to end operations executive who bridges strategy and execution to scale innovation in highly regulated, mission‑critical industries—transforming how MedTech organizations deliver value to patients. A proven change manager and growth leader, she brings more than 20 years of experience translating global strategy into manufacturing and operational execution to drive above‑market growth and bottom‑line impact. Jamie is recognized for leading large‑scale transformation initiatives, including building and overseeing complex, multi‑platform operations supporting business units of more than $15B in revenue. Her strategic operations expertise spans enterprise vision setting, innovation roadmaps, growth strategy, and disciplined downstream execution. She is passionate about building high‑performance teams that are customer‑focused, process‑driven, and results‑oriented.

Within BD, Jamie has applied this leadership across multiple global businesses over the past five years. She has served as an Executive End‑to‑End Operations Leader within the Global Medical segment, leading Vascular Access Devices (VAD), Injection Systems (IS), and Catheter Care (CC) sites for two years, followed by two years leading the Global Pharmaceutical Systems business in Switzerland. Most recently, following the Advanced Patient Monitoring acquisition, Jamie joined the Irvine California organization to lead Integrated Supply Chain (ISC) and enterprise integration efforts.

Prior to BD, Jamie spent 20 years in the automotive industry, leading global operations across discrete electronic components, engineered products, and tire manufacturing. As an executive leader within the Continental AG Tire Group, she created the Conti Life Cycle re‑tread business, led greenfield manufacturing initiatives, and built the Commercial Truck Tire brand portfolio. A proven innovator, Jamie launched patented, market‑disrupting technologies and implemented integrated digital systems that positioned the business as a supplier of choice. Throughout her career, she has directly led international teams spanning manufacturing, global supply chain, engineering, maintenance, project management, customer care, strategy, innovation, finance, and IT.

Jamie holds an MBA, a Bachelor of Science, and an Associate of Applied Science. She is a Six Sigma Master Black Belt, LEAN‑certified, a PMP‑certified Project Management Professional, and an ASE‑certified leader in continuous improvement.

Beyond her professional role, Jamie is an active advocate and executive sponsor for the Women’s Initiative Network (WIN), the Society of Women Engineers (SWE), and Women in Tech & Science (WITS), where she serves on the Executive Board. She also supports SheTech Engineering and STEM First Robotics and serves on the Board of Directors for Business Magazine. Jamie’s

mission is to Advance the World of Health by delivering high‑quality, on‑time, and cost‑effective solutions—with patients at the center of everything she does.

Arthur Leach is Senior Vice President of Global Manufacturing for Cardinal Health’s Global Medical Products and Distribution business. In this role, he is responsible for Cardinal Health’s self‑manufactured product portfolio and for directing surgical kitting across the Americas, Europe, and Asia.

With senior leadership experience at General Electric, Covidien/Medtronic, and Insulet, he brings a deep background in medical device operations. Over more than three decades, his leadership has spanned manufacturing, engineering, operational excellence, warehousing, supply chain, quality and finance. He also has a proven track record of designing and executing strategic and operational initiatives that drive continuous improvements in talent development, safety, quality, service, and cost.

Arthur earned his BA in Math and Science from Stonehill College, where he is currently a member of the Engineering Industry Advisory Board, and a BS in mechanical engineering from the University of Notre Dame.

Operations executive with a proven record of shaping and executing long‑term strategies aligned with corporate financial and strategic objectives. Recognized for driving transformative initiatives across Operations, Manufacturing, and Supply Chain, with a consistent history of turning ideas into measurable results. Leading the transformation of Operational Excellence culture in the North American B Braun Operation.

Jesse Freeman is the Senior Vice President of Global Operations at Globus Medical, with responsibility for all operational aspects of a $3b orthopedics company, primarily focused in the spine market. Key factors Jesse has been leading his team toward over the past 5 years have been scaling operations to meet Globus’ high single to low double digit CAGR, bringing large acquisitions of NuVasive and Nevro into the fold, and positioning the company to be able to make future acquisitions. Jesse’s depth of experience is in implantable and capital technologies where he held progressive leadership roles in manufacturing and supply chain with companies such as Globus, Zimmer Biomet, Stryker, and Caterpillar.

Jason P. Busch is Vice President of Quality Assurance & Regulatory Affairs at Medtronic, leading global Quality and Regulatory for the Ear, Nose & Throat (ENT) operating unit. With over 20 years of experience across pharmaceuticals, medical devices, and combination products, he oversees new product quality, post-market quality engineering, pharma compliance, and regulatory strategy.

Previously, Jason held multiple senior global quality leadership roles at Johnson & Johnson and Fresenius Medical Care, directing large, multi-site teams in quality systems, post-market surveillance, supplier quality, and field actions/recalls. He has led FDA Warning Letter remediations, EU MDR readiness, and quality integration for major robotics and digital surgery acquisitions. Jason holds a B.S. in Chemistry with a minor in Mathematics from Florida State University and is Green Belt certified, with additional certifications in software quality and project management.

Max Poeske is Senior Director of Global Supply Chain at Globus Medical, where he has responsibility for end-to-end supply chain operations supporting $2.9B in annual revenue across more than 50 countries. He leads global planning, procurement, inventory management, and new product launch activities spanning 250+ suppliers, five internal manufacturing sites, and distribution sites across the globe. Max has held key leadership roles in major merger and acquisition integrations, including the NuVasive acquisition in ’23 and most recently the acquisition of Nevro (spinal cord stimulation) in 2025. With experience in S&OP, forecasting, inventory optimization, and FDA-regulated manufacturing environments, he has focused on building scalable, disciplined supply chain capabilities that support enterprise growth, operational resilience, and informed executive decision-making.

Prabhu Gubbi received his Ph.D. in Materials Engineering from Auburn University and has > 20 years of work experience in medical device industry (including Zimmer Biomet Dental (now known as ZimVie), Somahlution & NuVasive) and a well-recognized notified body BSI.  He has intimate knowledge of MDD 93/42/EEC, MDR 2017/745, UKCA, and related EU guidance/regulations related to medical devices with dedicated training as well as has conducted technical reviews of Class IIa, IIb and III devices under MDD, MDR & UK MDR.  Prabhu is well-conversant with design controls, risk management, pre-clinical design verification testing, design validation, usability, biological safety assessment, packaging evaluation, clinical evaluation assessment, technical documentation assessment, labelling including eIFU EU regulation, subcontractor/supplier assessment, and various device manufacturing processes/activities.  He has also demonstrated expertise in the selection of optimal materials, characterization of materials behavior, failure analysis, formal mechanical testing of materials for medical devices and other applications in addition to the development of effective osseous implant surfaces including the use of resorbable blast media, titanium plasma spray, micro and nanometer-scale hydroxyapatite depositions, and surfaces modified with acid- and laser-etching techniques. He was also instrumental in developing implantable devices, components, and associated surgical techniques.

Medha serves as the Worldwide Vice President of Quality for BD’s (Becton, Dickinson and Company) Peripheral Intervention Business. BD is a leading global medical technology company headquartered in Franklin Lakes, New Jersey. Medha is a member of BD’s Quality Leadership Team and sits on the Senior Leadership Team for Peripheral Intervention Business.

She first joined BD in January 2022 as the Vice President of Quality for BD’s Medication Management Solutions business where she successfully led the Infusion platform through the design, 510(k) clearance and return-to-market of BD’s flagship Alaris Infusion Pump.

Before joining BD, Medha spent 15 years at Stryker Corporation in multiple roles of increasing responsibility in R&D, RAQA and Operations. Medha is known to build strong teams, foster collaboration, influence key stakeholders and deliver business success.

Prior to Stryker, Medha spent 5 years in multiple start-ups, designing and innovating software technologies and products.

Medha holds a B.S. in Computer Engineering from India and M.S. in Computer Science from Georgia Institute of Technology. She has completed a Global Leadership Program at Harvard Business School.

Chandresh serves as Head of Regulatory Compliance at Johnson & Johnson’s Robotics and Digital Solutions organization. A recognized leader in his field, he brings over 30 years of experience in digital transformation and business process automation. His strategic global leadership has enabled successful product launches, regulatory approvals, and quality system improvements across the medical device sector, including roles at Johnson & Johnson, Philips, and Becton Dickinson, spanning North America, Europe, Asia, and Latin America.

He has also contributed to the development of international medical device standards through IEC & ISO committees and previously led global compliance and medical device certification activities at Intertek’s Notified Body operations.

Based in Irvine, Chandresh has been married to his wife, Laxmi, for more than 20 years and is a proud father of two sons, Tej and Rudra. Outside of work, he is an avid sports enthusiast with a particular passion for cricket.

Operational Excellence and Quality Systems professional with 16 years of experience in the medical device industry. Combining deep expertise in Quality Systems based on FDA QSR and ISO 13485 with the Shingo Operational Excellence Model, he led the cultural transformation at ICU Medical Costa Rica. Adolfo designed strategies to align systems with OPEX principles, foster ideal behaviors, and ensure sustainable results over time, guiding the facility to earn the prestigious Shingo Silver Medallion in 2022.

Recognized as Shingo Rising Star 2024, Shingo Alumni, and Examiner Candidate, Adolfo holds certifications as ASQ Lean Six Sigma Black Belt and ICAgile Agile Coach (ICP-ACC). His career reflects a strong commitment to integrating excellence and regulatory compliance in highly regulated environments, blending technical expertise with strategic leadership.

Paul Arrendell is Chief Quality Officer at Jabil, providing global leadership for the company’s manufacturing, design, and supply chain operations within a large, multinational footprint. In this role, he partners closely with operations and business leaders to embed quality, reliability, and product realization excellence across complex, highly regulated and advanced manufacturing environments, including medical device, pharmaceutical, and healthcare sectors.

With more than 27 years in industry, Paul has held senior engineering, quality, regulatory, and operational leadership roles spanning semiconductor, aerospace/government, automotive, and medical technology environments, bringing a strong foundation in engineering, manufacturing system design, and product lifecycle execution at global scale. Prior to joining Jabil, he served as Worldwide Vice President of Quality Management at Becton Dickinson.

Paul holds a Bachelor of Science and a Master of Science in Engineering from The University of Texas at Arlington.

Matt Lowe has served MasterControl for nearly two decades across several different executive leadership roles including product, engineering, sales, and marketing, and now as Chief Strategy Officer. In this role, Lowe brings vast institutional knowledge of the market, MasterControl’s products, and customers to identify growth strategies and expansion opportunities for the company. He also serves on the MasterControl Board of Directors.

Lowe is a medical device expert with experience in product development and product management at Ortho Development Corp. and Bard Access Systems, a subsidiary of BD. Lowe has successfully launched more than a dozen medical devices. He has five patents issued and one pending. His regulatory experience includes writing a 510(k) that was cleared by the FDA and managing a multi-site, multi-year postmarket clinical study for orthopedic devices.Lowe has a bachelor’s degree in mechanical engineering from the University of Utah and an MBA from Indiana University.

Bart Reitter is Vice President of Sales for the Americas at Honeywell Life Sciences, and a seasoned veteran with over 30 years of experience in the enterprise software and Life Sciences industries. He is responsible for directing sales strategy and driving revenue growth for Honeywell’s portfolio of advanced SaaS and AI solutions across the Americas. His career is marked by expertise in leveraging technology to enhance operational efficiency and maintain regulatory compliance within the Life Sciences sector.

Prior to joining Honeywell, he served as Vice President of Sales for QAD as well as leading a global P&L focused on Life Sciences, where he was responsible for global strategy, solution positioning and product development.

He previously oversaw global marketing for a leading Contract Research Organization, gaining valuable perspective on the needs of this specialized industry and he also spent 10 years at General Electric, serving as the Global Industry Director for Life Sciences.

Reitter holds a Bachelor’s Degree in Marketing from Duquesne University and lives outside of Philadelphia with his wife and two daughters.

Michael brings more than 24 years of experience in the medical device industry to his role as the VP of Quality for the Orthopedics franchise at Smith+Nephew. He leads a global team responsible for the full product lifecycle from product development, through realization to post market surveillance. As a biomedical engineer with a track record of creative problem solving and leading multiple core business functions in both large and small companies, he is uniquely positioned to aid organizations in connecting strategies and processes across the business to optimize outcomes by balancing customer needs, compliance, and profitability.

As COO at Diality, a home hemodialysis startup, Jahnavi is responsible for the overall operations of the company. Over her career, she has been involved in a multitude of electromechanical and software medical devices. Her experience and leadership have been focused on developing and delivering medical device design and manufacturing services and solutions, providing outstanding client service, and driving profitable revenue growth.

Beth Crandall leads Solution Delivery at MEC with over 25 years of experience in the life sciences industry focused on the regulated medical device market. She has a successful track record of leading large quality management system programs and implementing changes to organizations, policies, procedures, and software systems. She also has direct experience conducting assessments for Quality and Regulatory organizations, including evaluation of processes, best practices, functional responsibilities, structure, and staffing. She earned a BA in Business Administration, Human Resource Management from the College of St. Thomas and has been a certified Project Manager (PMI PMP) since 2012. She has presented at several medical device conferences and published multiple articles throughout her career.

Philip Tocco is a senior operations and supply chain leader with deep experience driving large-scale transformation across complex, regulated manufacturing environments. He currently serves as Head of Supply Chain for the Monarch Platform at Johnson & Johnson MedTech Surgery, where he leads end-to-end supply chain strategy across engineering, manufacturing, quality, procurement, planning, and finance for a high-growth robotic platform.

Previously, Philip held senior leadership roles at Medtronic, where he led one of the company’s largest manufacturing sites supporting $1.7B in annual revenue. Known for translating strategy into execution, Philip has delivered step-change improvements in cost, capacity, service, and organizational health while building high-performing, people-centric teams. His work focuses on scaling innovation, strengthening resilience, and enabling sustainable performance.

Stephanie assumed her current role as DVP of Operations, Structural Heart in September 2024 and is based in Plymouth, Minnesota.

Stephanie started in Abbott in 2005 and after a brief absence, returned in 2018. She has held leadership positions in Abbott’s Vascular, Electrophysiology, and Structural Heart divisions. Previously, she served as Sr. Director, Operations in Structural Heart.

Stephanie earned a bachelor’s degree in Applied PhysicsElectronics from National University of Ireland Galway.

Stephanie enjoys spending time with her three small kids and loves to travel. She especially looks forward to visits back home to see family in Ireland.

Senior technology leader responsible for building and leading an engaged team to bring the world’s first SaaS Manufacturing Execution Systems product to market. Extensive experience of successful delivery of complex software projects transforming performance of some of the world’s largest and most successful manufacturing companies around the globe.

With 17 years of experience in chief executive leadership and board membership, Stefano has served as CEO for five international organizations: Lima, Inion, Corin, Aleva, and Elos. His professional career spans leadership positions in three established corporations and two startup ventures, each generating revenues of several hundred million euros. Stefano has managed companies headquartered in Italy (Lima Corporate), Finland (Inion), the United Kingdom (Corin Group), Switzerland (Aleva), and Sweden (Elos Medtech).

His notable achievements include overseeing two corporate delistings, one successful initial public offering, and leading twelve acquisitions across eight countries.

Stefano’s areas of expertise encompass:

• Orthopedics & Spine
• Dental Implants
• General Surgery and Pediatric Surgery
• Robotic-Assisted Surgery and Digital Surgery
• Contract Development and Manufacturing Organization (CDMO)

As CEO, Stefano has overseen and driven business growth totaling several hundred million euros through both organic and inorganic initiatives.

Quraish Baldiwala is the President Direct Supply Manufacturing Inc and Group Vice President Supply Chain & Manufacturing at Direct Supply in Milwaukee. Quraish and team have responsibility for all manufacturing, private label and third party manufacturers, original equipment suppliers and sourcing for the Direct Supply Manufacturing & Innovation business unit.

Prior to joining Direct Supply in November 2025, Quraish was the Vice President of Global Supply Chain & Operations at Sequel Med Tech for 2 years where he was one of the very first employees. At Sequel MedTech, Quraish established an end-to-end supply chain for contract manufacturing, procurement, planning, distribution, logistics, and Business Excellence that delivered a distribution margin of 3.2% in 2 years. Quraish spent 17+ years with Abbott where he held leadership positions with responsibility for global supply chain with Abbott Diagnostics, and Director & Head of Abbott Nutrition Supply Chain India region as his most recent roles. He was the winner of Abbott’s premier Chairman’s Award in 2019 for his leadership of the organization in India and the organization won The Shingo Prize in 2022. Quraish began his Abbott career in March 2006 as the supply chain manager for US operations and progressed to various roles in Supply Chain, Operations and Commercial both in the US and Internationally.

Quraish has also worked with General Mills and Gillette. He started his career as an Entrepreneur launching a startup company.

Quraish has a B.Engg. (Industrial) from the University of Mumbai, and both an MBA in Supply Chain & International Business and an MS in Operations Management from the University of Wisconsin-Madison. Quraish is based in Chicago and is a Lean Six Sigma Green Belt and certified in Class A, Mindful Leader and Influencer Training. He is a board member for non-profits, global coach, mentor, and aspiring epicurean.

Dave brings over 28 years of experience driving transformative outcomes for MedTech companies by revolutionizing how they digitally represent and manage their products across the lifecycle. His work empowers organizations to unlock efficiency, accelerate innovation, and deliver measurable ROI through digital thread enablement.

Professionally, Robbie has more than 25 years of experience in a GMP regulated industry including both pharmaceuticals and medical devices. Robbie is currently the SVP of Quality & Regulatory for a fast-growing CDMO which recently changed their name to Cordica Medical. This name reflects who we have become over the last several years, provides a renewed sense of purpose, and reflects our on-going commitment of Helping Those Who Help Others.

Personally, Robbie is the father of four nearly grown children, has the new title of “Grand-Dobbie” of one precious little granddaughter, and is the husband, also of one, beautiful lady whom he does life with. Robbie is a Christ follower and enjoys hearing redemption stories.

Raghu Aditham is a senior medical device leader with deep expertise in quality systems, operational excellence, and regulatory readiness. He is known for building resilient, patient-centric quality cultures that enable innovation at scale, especially through periods of growth and change. Raghu brings a clear, forward-looking leadership perspective on how strong quality foundations accelerate trust, performance, and long-term impact in medtech.

Kim Kaplan is Principal Product Manager at MDDAP, LLC (an ISACA subsidiary) and has been a key collaborator on the Case for Quality Voluntary Improvement Program (VIP) since the development of its pilot in 2017. She is a certified CMMI Associate and Appraisal Team Member for VIP, and now sits as a standing advisor on the VIP Governing Committee. Kim led the 2022 launch of the VIP Portal, a new data management tool to help program stakeholders track individual continuous improvement journeys as well as identify broader industry trends and insights.

Amra leads global government strategy at Veeva MedTech. Leveraging 25 years of experience in healthcare, she identifies challenges and opportunities in the medtech sector, fostering cross-functional collaboration and partnerships to effectively address these issues. While at Medtronic, she ensured market access for cardiovascular and other high-risk devices in multiple markets. Transitioning from regulatory submissions to advocacy and strategy, Amra represented her organization and the industry in external working groups, often assuming leadership roles.

Before joining Veeva MedTech, Amra contributed her expertise to Bayer AG and Abbott, focusing on regulatory intelligence for medical devices and spearheading global compliance initiatives.

Bachelor degree in Chemistry, master degree in HR management. 30 years of experience in Quality, starting from automotive, fashion, Pharma and medical devices. Experienced in all medical devices categories in the different regulations (FDA, EU MDR, Japan, Singapore, Canada just to name few of them). Leading Quality pre Clinical (GLP and non GLP studies),  Clinical and Commercial environment.  Experienced in leading remediation projects, lifting of warning letters, QMS integration, quality culture across organizations post acquisition, building team, unleashing team members potential, coaching and mentoring future leaders generation. Expert in strategy deployment and lean QMS and eQMS.

Sabyasachi Roy is Head of Regulatory Affairs for Enterprise Informatics, Innovation & Design at Philips, with over 14 years in the medical device industry. He specializes in regulatory strategies for AI, machine learning, and advanced sensor integration, particularly for software-enabled devices. Sabyasachi has led regulatory efforts from premarket through lifecycle management, bringing innovative solutions to areas such as traumatic brain injury, diabetes, and radiology. He has held leadership roles in both large and small companies and has experience in systems, biomedical, and research engineering. He holds a PhD in biomedical engineering from Johns Hopkins, an MS in electrical engineering from Montana State, and a BE from Bangalore University.

Greg Smith is Executive Vice President, Global Operations and Supply Chain at Medtronic. He is responsible for the performance and integration of all aspects of the company’s operations including Manufacturing, Supply Chain, Supply Management, Operational Excellence and Transformation, Enterprise Risk and Facilities, and Operations Quality.

Before joining Medtronic in April 2021, Greg was the Executive Vice President of U.S. Supply Chain at Walmart, one of the world’s largest and most complex supply chains. Greg transformed Walmart’s supply chain to be best in class, developing and implementing a comprehensive strategy that drove sales, achieved operational excellence, reduced costs, and that created an engaging, enabling, and empowering work environment.

Greg is deeply committed to diversity, equality, and the belief that a diverse workplace where everyone feels included results in stronger teams and the highest level of service to our patients, customers, and employees. He was recognized as a 2020 Diversity Leader by Diversity Journal (opens new window).

Before joining Walmart, Greg was Senior Vice President, Global Operations at The Goodyear Tire & Rubber Company, where he was responsible for 52 manufacturing facilities across four business units around the world. He successfully led the company’s global optimization program and implemented an enterprise manufacturing operating system, a global procurement program, and an enterprise planning and logistics approach.

In his more than 35 years of supply chain and operations experience, Greg has also transformed manufacturing, procurement, and logistics programs at companies including ConAgra Foods, United Signature Foods, VDK Frozen Foods, and Quaker Oats.

Greg earned his bachelor’s degree in finance from the University of Tennessee, Knoxville, and he currently serves on the College of Business advisory board. He serves on the GS1 Management Board and is the Vice Chairman of its Board Committee for Healthcare. Additionally, he serves on the board of directors for Advance Auto Parts, Inc. He is also a member of the Gartner Supply Chain Executive Advisory Board.

In his role as Head of Supply Chain & Operations for Philips Image Guided Therapy Devices, Cory is responsible to lead a world-class supply chain organization and to drive operational excellence in support of the business goals, which are fully focused on providing patient-focused and market-leading solutions. His passion for building a high-performing team of supply chain and operational leaders is rooted in his belief that there is always a better, more efficient way to serve our customers. Prior to entering the diagnostic / therapeutic medical devices industry, Cory spent over 20 years in development and leadership roles in the medical device and automotive industries.

Paudie O’Connor is the Senior Vice President for Global Supply Chain at Boston Scientific, a position he has held since May 2022. In this role, he serves on the company’s Executive Committee and is responsible for leading the world-class Global Supply Chain team, comprised of thousands of colleagues guided by its purpose of delivering for patients. Paudie’s career in healthcare and medical technology has spanned over 26 years, serving in various roles across management, operations and engineering. Previously, Paudie served as Vice President, Planning and Customer Experience at Boston Scientific from January 2021 to April 2022 and multi-site vice president, Manufacturing from February 2015 to January of 2021. Prior roles in Boston Scientific included Vice President of the Clonmel, Ireland site from January of 2009 to February of 2015 and various engineering and operations positions in the U.S. and Ireland from 1998 to 2008. Prior, Paudie worked for Aer Lingus, PRI Automation and Integer. He is the current sponsor of the Massachusetts PRIDE employee resource group. Paudie earned a B.A. in Mechanical Engineering from Trinity College in Dublin and a master’s degree in industrial engineering from University College Dublin.

In his role, Viju is responsible for global operations, including manufacturing, direct procurement, regulatory affairs, quality assurance, sustainability, integrated business planning, logistics and advanced operations such as additive manufacturing technology development.

Prior to joining us, Viju served as Chief Supply Chain Officer and Senior Vice President at Verizon. Before his work at Verizon, Viju held key leadership roles at Intel in technology, supply chain and manufacturing operations.

Viju earned his doctoral degree from the University of Pennsylvania and dual graduate degrees (MBA, S.M. in electrical engineering) from the Massachusetts Institute of Technology’s Leaders for Global Operations program. He also holds a graduate degree (M.S.E. in computer science engineering) from the University of Michigan and a bachelor’s degree in engineering from the University of Kerala, India.

Aileen Barreto Rivera is a transformational global leader with extensive experience in Supply Chain and Quality within the Medical Devices and Pharmaceuticals industry. Since joining Johnson & Johnson in 1995, Aileen has held multiple roles of increasing responsibility across various business units including Orthopedics, Vision Care, Diabetes Care and Innovative Medicine with direct accountability of Manufacturing, Lean, Engineering, and Quality functions. Her professional journey spans across key locations, including Puerto Rico, Europe, and the United States.

Throughout her tenure, Aileen has successfully led numerous strategic projects, including operational readiness for key product launches, site start up strategies and significant efficiency improvements within the manufacturing landscape. Her leadership has facilitated remarkable accomplishments, during acquisitions, compliance improvements initiatives, as well as significant contributions to community initiatives, reflecting her passion for people. Aileen’s commitment to excellence is evident in her ability to drive performance and engagement while maintaining high standards of quality and customer satisfaction.

Her academic background includes a Bachelor of Science in Electrical Engineering from the University of Puerto Rico, as well as an alumni of notable leadership programs at J&J.

John Daley brings over 30 years of FDA-regulated industry experience to Compliance Architects. As Chief Quality Officer at JUUL Labs, he secured its groundbreaking ISO-13485 certification. John has led Quality at Johnson & Johnson, Boston Scientific, and IBM Watson Health, where he also oversaw Privacy and Security. With expertise in Design Controls, CAPA processes, combination products, medical devices, pharmaceuticals, and consumer goods, John offers a wealth of knowledge. He holds a BSME from the University of Rhode Island and an MBA from SUNY Albany.

Chester Zelaya is the Senior Vice President of Implant Network Global Operations at Edwards Lifesciences, overseeing global facilities that support both Surgical Heart Valve and Trans-Catheter Divisions. With over 30 years of leadership experience in the biopharmaceutical and medical device industries, Chester has a proven track record of driving operational excellence across diverse, multi-plant environments. Prior to joining Edwards, he held senior roles at Shire and Baxter, where he managed large-scale plasma manufacturing operations and led significant global initiatives. Chester also serves as a board member for Heart to Heart Global Cardiac Care, helping to expand access to life-saving cardiac treatments in underserved regions. His strategic vision, technical expertise, and commitment to building high-performing teams contribute to his success as a leader in the healthcare industry.

David Kunz was appointed Senior Vice President, Global Quality and Regulatory Affairs in May 2017. He is responsible for providing strategic and operational direction to achieve Quality and Regulatory Excellence across the organization and he chairs the Company’s Quality Excellence Steering Committee. Mr. Kunz joined the Company (then Zimmer) in 2011 as Vice President, Regulatory Affairs and Quality Assurance for the Spine division. He was appointed Senior Vice President, Global Quality, Clinical and Regulatory Affairs in April 2016.  Prior to joining Zimmer, he served as Vice President, Quality Assurance of Ecolab, where he led a supply chain network including nine chemical plants and two equipment plants. Previously, he spent 13 years at Guidant/Boston Scientific Corporation in a variety of leadership positions, most recently as the Director of Supplier Quality Assurance for the CRV Division. He began his career at the Naval Nuclear Propulsion Program Headquarters as a mechanical engineer. Mr. Kunz holds a Bachelor of Science and an MBA from the University of Minnesota. He is a certified Nuclear Engineer and previously was a certified Licensed Professional Mechanical Engineer.

Robert Popp is a seasoned professional with over 35 years of experience, including executive management, spanning medical devices, pharmaceuticals, and biologics. His expertise encompasses service support, sales, marketing, quality, and manufacturing. Known for his customer-centric approach, Robert leverages strong analytical skills and business acumen to drive improvements in customer experience and regulatory compliance.

Robert excels in addressing regulatory challenges and implementing lean and compliant solutions. He has a proven ability to create sustainable revenue pipelines, expand market share, and enhance product quality while maximizing operating margin and net income delivery.

As a leader, Robert focuses on team development and innovation, inspiring engaged and high-performing teams to achieve organizational goals. He drives continuous improvement initiatives and collaborates with key stakeholders to develop and deploy policies, processes, and procedures that drive sustainability, quality, and service improvements across the board.

Dina is currently the Vice President of Regulatory Affairs for Terumo Medical Corporation where she oversees both US and global Regulatory Affairs. Prior to joining Terumo in 2008, Dina spent 17 years at the FDA as a reviewer and later a branch chief in the Division of Cardiovascular Devices. She also spent some time as a Sr. RA consultant prior to joining Terumo.

Dina holds a BS in Biomedical Engineering from The Catholic University of America and a Master of Business Administration from the University of Maryland.

Mark Mews leads the operations and supply chain for the Peripheral Business Group and has been at W.L. Gore and Associates, Inc. for over 16 years spending a majority of that time leading cross-functionally in various operations & supply chain leadership roles across both new product development and commercial life cycles. Mark is an advocate for continuous improvement, creating a lean culture, and focusing teams and organizations on delivering targets that improve both top and bottom-line growth.

Michael Ingles is Edwards Lifesciences Director of Business Excellence, orchestrating the global Operational Maturity Index (OMI) program. He leads an international team of experts assessing business areas across various manufacturing sites to ensure standardization and continuous improvement.

Michael also owns the Edwards Production System (EPS), providing plants with standardized work processes built upon proven principles, practices, and tools. His leadership is pivotal in maintaining world-class standards across the company’s global operations, including facilities in Singapore, Ireland, the Dominican Republic, Puerto Rico, Costa Rica, Utah, Irvine, California, and upcoming plants.

Mike joined Edwards Lifesciences in 2006, working in various roles in finance, project management, and strategy.

Mario Barquero is a manufacturing leader with over 20 years of experience in leadership roles within the medical device industry. As a Manufacturing Leader at Philips, Mario oversees operations across multiple manufacturing sites in Costa Rica and the United States, ensuring world-class quality, compliance, and patient-focused outcomes.

With a proven track record in strategic planning, operational excellence, and fostering high-performance cultures, Mario is passionate about aligning organizational strategies with patient impact. His leadership style emphasizes collaboration, innovation, and empowering teams to continuously improve processes and deliver solutions that enhance patient lives globally.

Throughout his career, Mario has successfully led cross-functional teams, driven sustainable practices, and championed a culture of accountability and empathy. His expertise spans lean manufacturing, quality systems, talent development, and leadership strategies to cultivate a patient-first mindset.

LINNETTE TORRES is the chief quality officer at Integra LifeSciences and is responsible for leading Integra’s quality assurance organization. She oversees critical quality programs such as the development and implementation of the enterprise-wide compliance master plan, quality operations, post-market surveillance activities, design assurance, complaint handling, and validation.

Linnette is a seasoned senior leader with extensive global experience in quality and operations and a record of accomplishments in the medical device industry. Prior to joining Integra, Linnette was at Edwards Lifesciences for more than two decades, most recently serving as senior vice president of quality in the Critical Care division. While at Edwards Lifesciences, she also founded the Hispanic employee resource group and created chapters worldwide.

Linnette completed her undergraduate degree in industrial engineering and postgraduate studies in quality management and productivity at the Instituto Tecnológico de Santo Domingo in the Dominican Republic. She holds an MBA from Pontificia Universidad Católica Madrey Maestra. Linnette is a certified ISO 13485 lead auditor and Six Sigma Green & Black Belt.

Peggy Hansen serves as General Manager of the Contract Development & Manufacturing Business at Regenity Biosciences and Senior Vice President of Quality, Regulatory & Clinical Affairs. Peggy has more than 25 years of experience in regulatory affairs, clinical research, and quality assurance of implantable medical devices and over 14 years in business development and marketing for Regenity. Before joining Regenity, Peggy was the Manager of Regulatory Affairs at SurModics, Inc., a company specializing in surface modification of medical devices, where she was responsible for the company’s regulatory affairs and quality compliance. Prior to working at SurModics, Peggy was at 3M Health Care, Medical Products Division and Cardiovascular Systems Division where she was responsible for U.S. and global regulatory filings with respect to the company’s class I, II, and III medical devices and combination products. She is a certified Regulatory Affairs Professional.

Jessica Swanson serves as Vice President of Marketing at Regenity Biosciences and is dedicated to improving lives globally through the development, commercialization, and impact of innovative healthcare devices. Prior to Regenity, Jessica served as Vice President of Global Marketing for the Breast and Skeletal Health Division at Hologic, Inc., leading a dynamic team focused on product management, integrated brand marketing, medical education, and sales training. During her tenure, she launched several new breast imaging, software, and surgery products, produced multiple award-winning marketing campaigns, and pioneered a groundbreaking health equity program. Prior to Hologic, Jessica spent several years with Medtronic, managing upstream marketing and partnering with R&D to develop numerous innovative products, including a novel endoscopic stapler with preloaded tissue reinforcement. She also led downstream commercialization for the US-based surgical devices business.

An accomplished Global Operations and Manufacturing leader with a proven track record of leading culture transformation and complex product development projects and teams for global operations. Deep background developing high-performing teams to deliver effective product solutions that improve business growth and brand reputation in competitive industries. History of driving success, working with complex multi-tiered private and Fortune 500 companies, advancing my career from product development engineering to senior leadership, overseeing complex product innovations, teams, corporate standardization and improvements.

Kim Kaplan is a Senior Product Manager at ISACA and has been a key collaborator on the Case for Quality Voluntary Improvement Program (VIP) since the development of its pilot in 2017. She is a certified CMMI Associate and Appraisal Team Member for VIP, and now sits as a standing advisor on the VIP Governing Committee. Kim led ISACA’s 2022 launch of the VIP Portal, a data management tool to help program stakeholders track individual continuous improvement journeys as well as identify broader industry trends and insights.

Alison Bagwell is the CEO of Nephron Nitrile, LLC, an American manufacturer of medical and general purpose gloves. Most recently, Alison served as CEO, President and founder of Shield Manufacturing LLC. Prior to founding Shield, Alison was an R&D engineer with 25 years’ experience in portfolio strategy and product development with Kimberly-Clark Corporation. Alison specializes in medical devices spanning PPE/healthcare suppliers, enteral access devices, fluid management, interventional pain management, neuromodulation, IV therapy, diagnostics, and point of care analytics and wound care. Alison holds over 50 patents of which 75% are still in use today.

Michelle Menendez serves as the Senior Director of Strategic Accounts at Premier’s research and analytics division, where she leads the development and cultivation of key relationships with life sciences partners. Leveraging data-driven insights and value-based solutions, she drives measurable outcomes that align with her clients’ strategic goals.

With a wealth of expertise in healthcare and sales leadership, Michelle excels in strategic account management, business development, and operational optimization. She began her career as a health educator at a regional cardiac hospital, a foundation she built upon to transition into the medical device sector. In this space, she held a series of leadership positions, where she spearheaded the transformation of national sales training programs, managed complex Integrated Delivery Network (IDN) accounts, and pioneered innovative health economics strategies.

A proud U.S. Army veteran, Michelle is recognized for her exceptional ability to execute business objectives, cultivate high-performing teams, and deliver impactful, sustainable solutions for both her clients and organizations. She holds a Master’s in Healthcare Administration and a Bachelor’s in Health Science, underscoring her strong academic foundation in the field.

Myla Maloney is the Chief Growth Officer for PINC AI™ Applied Sciences, a division of PINC AITM, the technology and services platform of Premier. With 24 years of experience in the healthcare industry, Maloney supports Premier’s mission of transforming healthcare by leading population health improvement collaboration between PINC AI Applied Sciences and life sciences organizations. Maloney has been with Premier for the last seven years and previously served as Premier’s Chief Commercial Officer, PAS and Vice President of Strategic Supplier Engagement, where she partnered with leading biopharmaceutical and IT companies.

Myla received her B.S. in business administration and MBA from East Carolina University.

Shibu joined Tecomet in August of 2021 as the Vice President of Quality Assurance and Regulatory and was promoted into his current role in August 2023. He is an experienced leader with over 20+ years’ experience successfully building and leading Quality and Regulatory teams in the medical device industry and is committed to assuring exceptional customer outcomes are achieved. Shibu is responsible for developing, leading and driving the strategy/execution of global quality, regulatory, while partnering with business leaders in obtaining world class customer experience and operational excellence.

Prior to joining Tecomet, Shibu lead the Regulatory Affairs and Quality Assurance at Lincotek Medical, Nanthealth, Endo Pharmaceuticals and Stryker in roles of increasing responsibility.

Shibu graduated from Florida International University with a Bachelor of Engineering Degree and a Master’s of Science in Mechanical Engineering Degree.

Jessica is currently the Corporate Vice President, Global Quality and Chief Regulatory Officer at Integra LifeSciences, based in Princeton, NJ. Integra is a ~$1.5B multinational company and global provider of neurosurgical solutions, regenerative technologies, and surgical instrumentation. Jessica oversees all global RA and QA activities and serves as a member of the Executive Leadership Team. In her tenure at Integra, Jessica transformed the non-centralized regulatory organization into a centralized, highly efficient organization. She oversees and supports global regulatory authority collaboration and regulatory strategies for U.S. Class I, II, and III products. She is also the executive sponsor for the company’s EU MDR program and oversees global QA activities including, but not limited to, design assurance, supplier reliability and validation, quality management system compliance, and post-market activities.

Prior to joining Integra, Jessica held leadership roles with increasing levels of responsibility in regulatory and clinical affairs for Hillrom, Becton Dickinson (BD), and CR Bard. Jessica is passionate about professional mentorship and has been an invited speaker for numerous industry medtech and women’s leadership forums. Jessica also serves on the University of Utah Board of Governors, Engineering Alumni Association Board, and Engineering National Advisory Council. Jessica holds a BSc in Civil Engineering, and a Masters of Engineering and PhD in Bioengineering.

Brian Curran oversees the success of MasterControl’s Manufacturing Excellence (Mx) solution in the quest to digitize the 80% of life sciences manufacturing, large and small, that still use paper for their batch records or device history records. Curran has the privilege of working externally with Mx customers and internally across MasterControl from R&D to sales, services, and support to ensure Mx success and adoption.

Curran joined MasterControl in 2002 to direct and expand MasterControl’s product lines. In 2017 he switched to focus on bringing Mx to market, which happened mid-2019 and now has well over 100 customers who have completed hundreds of thousands of production records.

Curran began his career with IBM, where he led consulting engagements with Fortune 500 companies, such as MCI, Bellsouth, and others. After this he held several director and VP level product management positions for software companies serving the telecommunications and web analytics sectors. Curran has an MBA with an information systems emphasis.

Bill Darcy is a manufacturing quality engineer at Carestream Health based in Rochester, NY. Carestream is a worldwide provider of medical imaging systems; X-ray imaging systems for non-destructive testing; and precision contract coating services for a wide range of industrial, medical, electronic and other applications —all backed by a global service and support network. He also supervises the Document Control Administrators and Manufacturing Quality Technicians on the production line. Additionally, Bill led the launch of MasterControl as the electronic production record system for the equipment manufacturing sites at Carestream globally. This effort has led to increased compliance as well as improved speed and data management for device history records. Prior to Carestream, Bill was a corporate accountant in the private sector as well as a public accountant with PricewaterhouseCoopers.

Vishaka Rajaram’s role as senior director of quality at Veeva MedTech brings together three things she cares deeply about – medtech, quality, and technology. 

Prior to joining Veeva, Vishaka drove digital quality transformations for medtech and biopharma clients as a senior director at PwC. She guided clients through ROI-based digital transformation business cases, strategic system selection, future-state EQS landscape design, business process design/readiness & requirements development for configuration, implementation, UAT, training, and hypercare. She also led PwC’s alliance with a third-party to develop AI/ML and advanced analytics offerings to drive predictive quality.

Prior to PwC, she spent nearly a decade within the medical device industry at Stryker and Zimmer, in both corporate and site quality roles.

Vishaka holds a bachelor’s degree in Electronics & Communications Engineering from the University of Madras and an MSE in Biomedical Engineering from the University of Michigan.

Zillery A. Fortner is a respected professional in the life sciences industry with over 30 years of experience. She has held roles like surgical assistant, quality assurance specialist, regulatory affairs expert, and accreditation professional. Now, she is the Industry Business Development Director, SME at Honeywell, advocating for customers.

Her dedication to innovation is evident in her involvement in professional organizations and her numerous patents. Zillery’s extensive knowledge helps drive digital innovation and ensure regulatory compliance in the industry.